Page 20 - National Key Rd Program Of China News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Study Finds Social Intelligence to be AI s Next Barrier

While Siri and Google Assistant may be able to organize meetings on demand, they currently lack the social intelligence to prioritize the appointments on their own.

Zhihao caoChun zhuYixin zhuSkyla bailyManjie xuNova programTsinghua university department of automationArtificial intelligence researchUniversity institute for artificial intelligenceNational key laboratoryInstitute of technology school computer scienceTsinghua universityNational key rd program of chinaGoogle assistantIntelligence researchArtificial social intelligence

A bispecific glycopeptide spatiotemporally regulates tumor microenvironment for inhibiting bladder cancer recurrence

A bispecific glycopeptide spatiotemporally regulates tumor microenvironment for inhibiting bladder cancer recurrence
science.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from science.org Daily Mail and Mail on Sunday newspapers.

Anova nanoCell signaling technology incInstitute of boiphysicsChinese academy of scienceCommittee for animal research of national centerChengzhi kewei biotechnology coNational key rd program of chinaLaboratory animalsNational natural science foundation of chinaCore facility for protein researchSolarbio science technology coInstitute of basic medicineCell culture centerAbcam trading coVital river laboratory animal technology coBiolegend beijing ltd

Global 6G Conference 2023 Set for March

/PRNewswire/ This is a report from Science and Technology Daily: With the theme "Better Together, Better Future," the Global 6G Conference 2023 will be.

Seizo onoeWu hequanLiu yunjieTelecommunication standardization bureauChinese academy of engineeringTechnology dailyCommunication forum fuGround networkInternational telecommunication unionG network architecture native securityNational key rd program of chinaBetter futureFuture mobile communication forumPurple mountain laboratoriesChina jiangsuUse cases

Significant Progress Made on the Trivalent Recombinant Protein COVID-19 Vaccine against Subvariants including XBB 1 5 and BA 5 by WestVac Biopharma

Significant Progress Made on the Trivalent Recombinant Protein COVID-19 Vaccine against Subvariants including XBB 1 5 and BA 5 by WestVac Biopharma
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Westvac biopharmaWestvac biopharma co ltdKnowledge city of guangzhou economic development zoneInnovative vaccine productionNational key rd program of chinaWestvac biopharma guangzhou co ltdNational key rd programRecombinant variantVac biopharmaInnovative vaccine production baseKnowledge cityGuangzhou economic developmentClinical trial

WestVac BioPharma Co , Ltd : Significant Progress Made on the Trivalent Recombinant Protein COVID-19 Vaccine against Subvariants including XBB 1 5 and BA 5 by WestVac Biopharma

CHENGDU, China, Feb. 20, 2023 /PRNewswire/ Recently, with the support of the National Key R&D Program of China, following the clinical trial approval for Recombinant Variant COVID-19 Vaccine

Dennis riedlWestvac biopharmaWestvac biopharma co ltdKnowledge city of guangzhou economic development zoneInnovative vaccine productionNational key rd program of chinaWestvac biopharma guangzhou co ltdNational key rd programRecombinant variantVac biopharmaInnovative vaccine production baseKnowledge cityGuangzhou economic developmentClinical trial